Skip to main content

Nugen Pockets $100K SBIR Grant for Anthrax Assay

NEW YORK, Aug. 8 - Nugen Technologies has won a $100,000 phase I SBIR grant from the US National Institutes of Health to develop an anthrax detection assay, the company said on Monday.

 

Nugen said it will use its SPIA technology to amplify and detect B. anthracis DNA sequences. The company stressed it will not be working directly with anthrax spores.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.